300723 一品红
交易中 11-07 10:58:00
资讯
新帖
简况
股市必读：一品红(300723)股东户数2.07万户，较上期增加9.42%
证券之星 · 11-06 01:16
股市必读：一品红(300723)股东户数2.07万户，较上期增加9.42%
一品红：截止至2025年10月31日股东总户数20,721户
证券之星 · 11-05 08:27
一品红：截止至2025年10月31日股东总户数20,721户
一品红（300723）2025年三季报简析：亏损收窄，三费占比上升明显
证券之星 · 10-31
一品红（300723）2025年三季报简析：亏损收窄，三费占比上升明显
一品红(300723.SZ)发布前三季度业绩，归母净亏损1.36亿元
智通财经 · 10-29
一品红(300723.SZ)发布前三季度业绩，归母净亏损1.36亿元
图解一品红三季报：第三季度单季净利润同比增长78.65%
证券之星 · 10-29
图解一品红三季报：第三季度单季净利润同比增长78.65%
一品红(300723)9月30日股东户数1.89万户，较上期减少11.34%
证券之星 · 10-29
一品红(300723)9月30日股东户数1.89万户，较上期减少11.34%
一品红(300723.SZ)子公司获甲硫酸新斯的明注射液注册证书
智通财经 · 10-17
一品红(300723.SZ)子公司获甲硫酸新斯的明注射液注册证书
股市必读：一品红（300723）10月14日收盘跌14.3%，主力净流出5506.32万元
证券之星 · 10-15
股市必读：一品红（300723）10月14日收盘跌14.3%，主力净流出5506.32万元
股市必读：一品红(300723)股东户数1.89万户，较上期减少11.34%
证券之星 · 10-13
股市必读：一品红(300723)股东户数1.89万户，较上期减少11.34%
一品红：截止至2025年9月30日股东总户数18,937户
中金财经 · 10-10
一品红：截止至2025年9月30日股东总户数18,937户
10月9日一品红跌5.28%，易方达医疗保健行业混合A基金重仓该股
证券之星 · 10-09
10月9日一品红跌5.28%，易方达医疗保健行业混合A基金重仓该股
一品红最新公告：全资子公司获得左卡尼汀口服溶液注册证书
证券之星 · 09-28
一品红最新公告：全资子公司获得左卡尼汀口服溶液注册证书
一品红(300723.SZ)：馥感啉颗粒获药物临床试验批准
智通财经 · 09-22
一品红(300723.SZ)：馥感啉颗粒获药物临床试验批准
一品红(300723.SZ)子公司获得磷酸奥司他韦胶囊药品补充申请批准通知书
智通财经 · 09-19
一品红(300723.SZ)子公司获得磷酸奥司他韦胶囊药品补充申请批准通知书
一品红(300723.SZ)：盐酸克林霉素棕榈酸酯颗粒获注册证书
智通财经网 · 09-15
一品红(300723.SZ)：盐酸克林霉素棕榈酸酯颗粒获注册证书
9月10日一品红跌10.41%，易方达医疗保健行业混合A基金重仓该股
证券之星 · 09-10
9月10日一品红跌10.41%，易方达医疗保健行业混合A基金重仓该股
一品红：截止至2025年8月31日，公司股东总户数21,360户
证券之星 · 09-10
一品红：截止至2025年8月31日，公司股东总户数21,360户
9月4日一品红跌7.58%，易方达医疗保健行业混合A基金重仓该股
证券之星 · 09-04
9月4日一品红跌7.58%，易方达医疗保健行业混合A基金重仓该股
一品红最新公告：全资子公司获得注射用硫酸艾沙康唑注册证书
证券之星 · 09-01
一品红最新公告：全资子公司获得注射用硫酸艾沙康唑注册证书
9月1日一品红涨10.91%，易方达医疗保健行业混合A基金重仓该股
证券之星 · 09-01
9月1日一品红涨10.91%，易方达医疗保健行业混合A基金重仓该股
加载更多
公司概况
公司名称：
一品红药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2017-11-16
主营业务：
一品红药业集团股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是化学药(含原料药和制剂)、特色中成药等。公司曾先后获得中国化药研发综合实力百强企业、中国创新力医药企业100强和中国化药企业百强企业等荣誉称号，是广州生物医药产业链的链主企业。
发行价格：
17.05
{"stockData":{"symbol":"300723","market":"SZ","secType":"STK","nameCN":"一品红","latestPrice":49.29,"timestamp":1762484280000,"preClose":49.85,"halted":0,"volume":2684627,"delay":0,"changeRate":-0.0112,"floatShares":418000000,"shares":451999999,"eps":-0.9511,"marketStatus":"交易中","change":-0.56,"latestTime":"11-07 10:58:00","open":49.85,"high":50.08,"low":48.95,"amount":133000000,"amplitude":0.0227,"askPrice":49.29,"askSize":3,"bidPrice":49.28,"bidSize":3,"shortable":0,"etf":0,"ttmEps":-0.9511,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1762486200000},"marketStatusCode":2,"adr":0,"adjPreClose":49.85,"symbolType":"stock","openAndCloseTimeList":[[1762479000000,1762486200000],[1762491600000,1762498800000]],"highLimit":54.84,"lowLimit":44.87,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":451692766,"isCdr":false,"pbRate":12.86,"roa":"--","roe":"--","epsLYR":-1.1956,"committee":0.704225,"marketValue":22264000000,"turnoverRate":0.0064,"status":1,"floatMarketCap":20587000000},"requestUrl":"/m/hq/s/300723","defaultTab":"news","newsList":[{"id":"2581777777","title":"股市必读：一品红(300723)股东户数2.07万户，较上期增加9.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581777777","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581777777?lang=zh_cn&edition=full","pubTime":"2025-11-06 01:16","pubTimestamp":1762362976,"startTime":"0","endTime":"0","summary":"截至2025年11月5日收盘，一品红报收于50.13元，下跌2.94%，换手率2.15%，成交量8.97万手，成交额4.51亿元。当日关注点来自交易信息汇总：11月5日主力资金净流出1637.29万元，显示主力短期谨慎态度。来自股本股东变化：截至2025年10月31日，公司股东户数环比增长9.42%，户均持股数量下降至2.18万股。股本股东变化股东户数变动近日一品红披露，截至2025年10月31日公司股东户数为2.07万户，较9月30日增加1784.0户，增幅为9.42%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110600000994.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300723"],"gpt_icon":0},{"id":"2581791434","title":"一品红：截止至2025年10月31日股东总户数20,721户","url":"https://stock-news.laohu8.com/highlight/detail?id=2581791434","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581791434?lang=zh_cn&edition=full","pubTime":"2025-11-05 08:27","pubTimestamp":1762302444,"startTime":"0","endTime":"0","summary":"证券之星消息，一品红(300723)11月04日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止至2025年10月20日收盘公司股东人数为多少，谢谢！一品红回复：尊敬的投资者您好，感谢您对公司的关注。截止至2025年10月31日，公司股东总户数20,721户。祝您投资愉快。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500005374.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300723"],"gpt_icon":0},{"id":"2579610126","title":"一品红（300723）2025年三季报简析：亏损收窄，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2579610126","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579610126?lang=zh_cn&edition=full","pubTime":"2025-10-31 06:52","pubTimestamp":1761864779,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期一品红发布2025年三季报。截至本报告期末，公司营业总收入8.14亿元，同比下降34.35%，归母净利润-1.36亿元，同比上升44.8%。按单季度数据看，第三季度营业总收入2.3亿元，同比下降29.66%，第三季度归母净利润-6254.1万元，同比上升78.65%。本报告期一品红三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达56.21%。），公司上市来已有年报7份，亏损年份1次，需要仔细研究下有无特殊原因。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100010148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300723"],"gpt_icon":0},{"id":"2579900805","title":"一品红(300723.SZ)发布前三季度业绩，归母净亏损1.36亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579900805","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579900805?lang=zh_cn&edition=full","pubTime":"2025-10-29 22:40","pubTimestamp":1761748811,"startTime":"0","endTime":"0","summary":"智通财经APP讯，一品红(300723.SZ)发布2025年三季度报告，该公司前三季度营业收入为8.14亿元，同比减少34.35%。归属于上市公司股东的净亏损为1.36亿元。归属于上市公司股东的扣除非经常性损益的净亏损为1.79亿元。基本每股亏损为0.3013元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1362281.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"一品红(300723.SZ)发布前三季度业绩，归母净亏损1.36亿元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","300723"],"gpt_icon":0},{"id":"2579701089","title":"图解一品红三季报：第三季度单季净利润同比增长78.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579701089","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579701089?lang=zh_cn&edition=full","pubTime":"2025-10-29 19:43","pubTimestamp":1761738210,"startTime":"0","endTime":"0","summary":"证券之星消息，一品红2025年三季报显示，前三季度公司主营收入8.14亿元，同比下降34.35%；归母净利润-1.36亿元，同比上升44.8%；扣非净利润-1.79亿元，同比下降4916.67%；其中2025年第三季度，公司单季度主营收入2.3亿元，同比下降29.66%；单季度归母净利润-6254.1万元，同比上升78.65%；单季度扣非净利润-7089.35万元，同比下降127.49%；负债率60.26%，投资收益1528.16万元，财务费用4012.9万元，毛利率59.23%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900040507.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300723"],"gpt_icon":0},{"id":"2579978229","title":"一品红(300723)9月30日股东户数1.89万户，较上期减少11.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579978229","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579978229?lang=zh_cn&edition=full","pubTime":"2025-10-29 17:36","pubTimestamp":1761730602,"startTime":"0","endTime":"0","summary":"证券之星消息，近日一品红披露，截至2025年9月30日公司股东户数为1.89万户，较8月31日减少2423.0户，减幅为11.34%。在化学制药行业个股中，一品红股东户数低于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.38万户。从股价来看，2025年8月31日至2025年9月30日，一品红区间跌幅为10.48%，在此期间股东户数减少2423.0户，减幅为11.34%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900036605.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300723"],"gpt_icon":0},{"id":"2576081463","title":"一品红(300723.SZ)子公司获甲硫酸新斯的明注射液注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2576081463","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576081463?lang=zh_cn&edition=full","pubTime":"2025-10-17 15:56","pubTimestamp":1760687796,"startTime":"0","endTime":"0","summary":"智通财经APP讯，一品红(300723.SZ)公告，公司全资子公司广州市联瑞制药有限公司于近日收到国家药品监督管理局核准签发的关于甲硫酸新斯的明注射液的《药品注册证书》。甲硫酸新斯的明注射液适应症为：抗胆碱酯酶药。用于手术结束时拮抗非去极化肌肉松弛药的残留肌松作用，用于重症肌无力，手术后功能性肠胀气及尿潴留等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1356332.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"一品红(300723.SZ)子公司获甲硫酸新斯的明注射液注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","300723"],"gpt_icon":0},{"id":"2575243125","title":"股市必读：一品红（300723）10月14日收盘跌14.3%，主力净流出5506.32万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575243125","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575243125?lang=zh_cn&edition=full","pubTime":"2025-10-15 01:10","pubTimestamp":1760461819,"startTime":"0","endTime":"0","summary":"截至2025年10月14日收盘，一品红报收于52.98元，下跌14.3%，换手率4.12%，成交量17.2万手，成交额9.79亿元。交易信息汇总股价提醒10月14日一品红收盘报52.98元，跌14.3%，当日成交1719.8万元。该股近5个交易日中有2日跌幅超5%。前10个交易日资金流向情况：主力资金累计净流入1.28亿元，股价累计下跌13.46%；融资余额累计增加1232.09万元，融券余量累计增加2.03万股。资金流向10月14日主力资金净流出5506.32万元；游资资金净流入8364.96万元；散户资金净流出2858.64万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101500001059.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300723","BK0239"],"gpt_icon":0},{"id":"2575419973","title":"股市必读：一品红(300723)股东户数1.89万户，较上期减少11.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575419973","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575419973?lang=zh_cn&edition=full","pubTime":"2025-10-13 00:58","pubTimestamp":1760288296,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，一品红报收于58.28元，上涨3.54%，换手率2.68%，成交量11.2万手，成交额6.53亿元。股本股东变化股东户数变动近日一品红披露，截至2025年9月30日公司股东户数为1.89万户，较8月31日减少2423.0户，减幅为11.34%。本次员工持股计划通过非交易过户方式取得公司回购股份5,116,105股，占总股本的1.13%，过户完成日为2024年10月11日。员工持股计划将在符合监管要求的前提下择机处置权益，且在敏感期不得买卖公司股票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300000361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300723","BK0239"],"gpt_icon":0},{"id":"2574996119","title":"一品红：截止至2025年9月30日股东总户数18,937户","url":"https://stock-news.laohu8.com/highlight/detail?id=2574996119","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574996119?lang=zh_cn&edition=full","pubTime":"2025-10-10 08:52","pubTimestamp":1760057526,"startTime":"0","endTime":"0","summary":"证券之星消息，一品红(300723)10月09日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止至2025年9月30日收盘公司股东人数为多少，谢谢！一品红回复：尊敬的投资者您好，感谢您对公司的关注。截止至2025年9月30日，公司股东总户数18,937户。祝您投资愉快。为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251010/31695149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","300723"],"gpt_icon":0},{"id":"2574132903","title":"10月9日一品红跌5.28%，易方达医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2574132903","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574132903?lang=zh_cn&edition=full","pubTime":"2025-10-09 16:47","pubTimestamp":1759999639,"startTime":"0","endTime":"0","summary":"证券之星消息，10月9日一品红跌5.28%，收盘报56.29元，换手率2.24%，成交量9.34万手，成交额5.34亿元。重仓一品红的前十大公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共61家，其中持有数量最多的公募基金为易方达基金的易方达医疗保健行业混合A。易方达医疗保健行业混合A目前规模为39.44亿元，最新净值4.444，较上一交易日上涨1.72%，近一年上涨27.15%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900021103.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300723"],"gpt_icon":0},{"id":"2570434628","title":"一品红最新公告：全资子公司获得左卡尼汀口服溶液注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2570434628","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570434628?lang=zh_cn&edition=full","pubTime":"2025-09-28 16:30","pubTimestamp":1759048233,"startTime":"0","endTime":"0","summary":"一品红公告称，公司全资子公司广州一品红制药有限公司近日收到国家药品监督管理局核准签发的左卡尼汀口服溶液《药品注册证书》。左卡尼汀口服溶液适应症包括原发性系统性卡尼汀缺乏症和先天性代谢异常导致的继发性卡尼汀缺乏症。该产品为国家医保乙类产品，获批视同通过一致性评价。2024年在中国城市和县级公立医院的销售规模约为12.57亿元。此次获得注册证书将丰富公司产品管线，增强在慢病药领域的竞争力，对公司销售产生积极影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092800005245.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300723","BK0239"],"gpt_icon":0},{"id":"2569781911","title":"一品红(300723.SZ)：馥感啉颗粒获药物临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2569781911","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569781911?lang=zh_cn&edition=full","pubTime":"2025-09-22 19:43","pubTimestamp":1758541430,"startTime":"0","endTime":"0","summary":"智通财经APP讯，一品红(300723.SZ)公告，公司全资子公司广州一品红制药有限公司(简称：一品红制药)申报的馥感啉颗粒于近日获得国家药品监督管理局签发的药物临床试验批准通知书，同意本品开展用于成人气虚感冒的临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1348093.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"一品红(300723.SZ)：馥感啉颗粒获药物临床试验批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","300723"],"gpt_icon":0},{"id":"2568236799","title":"一品红(300723.SZ)子公司获得磷酸奥司他韦胶囊药品补充申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2568236799","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568236799?lang=zh_cn&edition=full","pubTime":"2025-09-19 11:50","pubTimestamp":1758253840,"startTime":"0","endTime":"0","summary":"同时批准如下关联补充申请事项：1、变更处方中的辅料用量;2、变更包装材料和容器;3、注册标准变更。变更后的生产工艺及质量标准照所附执行，有效期12个月，说明书及包装标签做相应修订，其他执行原批准信息。此次公司新增获得磷酸奥司他韦胶囊药品补充申请批准通知书，标志着公司具备了在国内市场销售该规格药品的资格，将进一步丰富公司产品管线和产品品类，对公司销售产生积极影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1347165.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"一品红(300723.SZ)子公司获得磷酸奥司他韦胶囊药品补充申请批准通知书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300723","BK0239"],"gpt_icon":0},{"id":"2567115511","title":"一品红(300723.SZ)：盐酸克林霉素棕榈酸酯颗粒获注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2567115511","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567115511?lang=zh_cn&edition=full","pubTime":"2025-09-15 18:55","pubTimestamp":1757933748,"startTime":"0","endTime":"0","summary":"智通财经APP讯，一品红(300723.SZ)公告，公司全资子公司广州一品红制药有限公司于近日收到国家药品监督管理局核准签发的关于盐酸克林霉素棕榈酸酯颗粒的《药品注册证书》。克林霉素适用于由敏感厌氧菌引起的严重感染。克林霉素适用于由链球菌、肺炎球菌和葡萄球菌等敏感菌株引起的严重感染，但仅适用于对青霉素过敏的患者或经医生判断不宜使用青霉素的患者。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1345381.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["300723","BK0239"],"gpt_icon":0},{"id":"2566676187","title":"9月10日一品红跌10.41%，易方达医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2566676187","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566676187?lang=zh_cn&edition=full","pubTime":"2025-09-10 16:20","pubTimestamp":1757492457,"startTime":"0","endTime":"0","summary":"证券之星消息，9月10日一品红跌10.41%，收盘报61.42元，换手率5.28%，成交量22.04万手，成交额13.67亿元。重仓一品红的前十大公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家。根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共61家，其中持有数量最多的公募基金为易方达基金的易方达医疗保健行业混合A。易方达医疗保健行业混合A目前规模为39.44亿元，最新净值4.62，较上一交易日下跌1.3%，近一年上涨59.15%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091000025930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300723","BK0239"],"gpt_icon":0},{"id":"2566967564","title":"一品红：截止至2025年8月31日，公司股东总户数21,360户","url":"https://stock-news.laohu8.com/highlight/detail?id=2566967564","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566967564?lang=zh_cn&edition=full","pubTime":"2025-09-10 15:48","pubTimestamp":1757490488,"startTime":"0","endTime":"0","summary":"证券之星消息，一品红(300723)09月10日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司8月31日和9月10日的股东人数分别是多少？谢谢一品红回复：尊敬的投资者您好，感谢您对公司的关注。截止至2025年8月31日，公司股东总户数21,360户。祝您投资愉快。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091000022171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300723","BK0239"],"gpt_icon":0},{"id":"2564322486","title":"9月4日一品红跌7.58%，易方达医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2564322486","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564322486?lang=zh_cn&edition=full","pubTime":"2025-09-04 16:35","pubTimestamp":1756974959,"startTime":"0","endTime":"0","summary":"证券之星消息，9月4日一品红跌7.58%，收盘报67.27元，换手率2.99%，成交量12.48万手，成交额8.78亿元。重仓一品红的前十大公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家。根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共61家，其中持有数量最多的公募基金为易方达基金的易方达医疗保健行业混合A。易方达医疗保健行业混合A目前规模为39.44亿元，最新净值4.877，较上一交易日上涨2.09%，近一年上涨68.35%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090400025481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300723","BK0239"],"gpt_icon":0},{"id":"2564815678","title":"一品红最新公告：全资子公司获得注射用硫酸艾沙康唑注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2564815678","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564815678?lang=zh_cn&edition=full","pubTime":"2025-09-01 17:50","pubTimestamp":1756720229,"startTime":"0","endTime":"0","summary":"一品红(300723.SZ)公告称，公司全资子公司广州一品红制药有限公司收到国家药品监督管理局核准签发的注射用硫酸艾沙康唑的《药品注册证书》。该药品主要用于治疗成人患者的侵袭性曲霉病和侵袭性毛霉病，属于化学药品4类，视同通过一致性评价。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090100024797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300723","BK0239"],"gpt_icon":0},{"id":"2564890534","title":"9月1日一品红涨10.91%，易方达医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2564890534","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564890534?lang=zh_cn&edition=full","pubTime":"2025-09-01 16:29","pubTimestamp":1756715382,"startTime":"0","endTime":"0","summary":"证券之星消息，9月1日一品红涨10.91%，收盘报73.63元，换手率4.28%，成交量17.86万手，成交额12.82亿元。重仓一品红的前十大公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家。根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共61家，其中持有数量最多的公募基金为易方达基金的易方达医疗保健行业混合A。易方达医疗保健行业混合A目前规模为39.44亿元，最新净值4.684，较上一交易日上涨2.7%，近一年上涨61.35%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090100021312.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300723"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1762484283840,"stockEarnings":[{"period":"1week","weight":-0.0202},{"period":"1month","weight":-0.1612},{"period":"3month","weight":-0.267},{"period":"6month","weight":0.3866},{"period":"1year","weight":2.2037},{"period":"ytd","weight":1.922}],"compareEarnings":[{"period":"1week","weight":0.0052},{"period":"1month","weight":0.0322},{"period":"3month","weight":0.1025},{"period":"6month","weight":0.1992},{"period":"1year","weight":0.1844},{"period":"ytd","weight":0.1957}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"一品红药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"20721人(较上一季度增加9.42%)","perCapita":"20156股","listingDate":"2017-11-16","address":"广东省广州市黄埔区广州国际生物岛寰宇一路27号云润大厦17层","registeredCapital":"45169万元","survey":" 一品红药业集团股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是化学药(含原料药和制剂)、特色中成药等。公司曾先后获得中国化药研发综合实力百强企业、中国创新力医药企业100强和中国化药企业百强企业等荣誉称号，是广州生物医药产业链的链主企业。","listedPrice":17.05},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.5","shortVersion":"4.35.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"一品红(300723)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供一品红(300723)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"一品红,300723,一品红股票,一品红股票老虎,一品红股票老虎国际,一品红行情,一品红股票行情,一品红股价,一品红股市,一品红股票价格,一品红股票交易,一品红股票购买,一品红股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"一品红(300723)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供一品红(300723)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}